• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    FibroBiologics, Inc. - Common Stock (NQ:FBLG)

    0.9900 -0.0100 (-1.00%)
    Delayed Quote Updated: 1:19 PM EDT, Oct 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9,105
    Open 1.020
    Bid (Size) 0.9700 (100)
    Ask (Size) 0.9998 (300)
    Prev. Close 1.000
    Today's Range 0.9691 - 1.040
    52wk Range 0.6201 - 9.654
    Shares Outstanding 38,262,586
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Nova Minerals and FibroBiologics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
    From RedChip Companies, Inc. (Media Suite)
    Via ACCESS Newswire
    News headline image
    Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications
    Learn how FibroBiologics is developing an off-the-shelf therapeutic platform designed to harness the regenerative and immune-modulating properties of fibroblasts Management to discuss the ongoing Phase... 
    From RedChip Companies, Inc. (Media Suite)
    Via ACCESS Newswire

    Performance

    52-Week Range 89.7% below 52-week high
    0.9900
    0.6252W Low 9.6552W High
    1 Week 17.5% below 1-week high
    0.921W Low 1.201W High

    FibroBiologics, Inc. - Common Stock (FBLG) traded between $0.62 and $9.65 over the past 52 weeks and last traded at $0.99, 89.7% below its 52-week high. Over the past week it ranged between $0.92 and $1.20.

    Past 12 Months
    -12.4%
    -31.2%
    +17.9%
    -34.9%
    -79.4%
    -89.0%
    1W -$0.14
    1M -$0.45
    3M +$0.15
    6M -$0.53
    YTD -$3.81
    1Y -$8.01

    FBLG was -89.0% over the past year, -34.9% over six months, -79.4% year to date, -12.4% in the last week.

    12 Months vs Market
    FBLG
    -89.0%
    DIA
    +12.0%
    SPY
    +14.7%
    QQQ
    +18.2%
    IWM
    +8.0%

    Over the past 12 months FBLG returned -89.0% versus DIA (Dow) +12.0%, SPY (S&P 500) +14.7%, QQQ (Nasdaq 100) +18.2% and IWM (Russell 2000) +8.0%.

    Volume & Liquidity 0.04× 3-mo avg
    Today 9,105 3-mo avg 208.6K
    1W
    136.1K
    1M
    142.2K
    3M
    208.6K
    6M
    219.5K
    YTD
    245.0K
    1Y
    212.8K

    FBLG most recently traded 9,105 shares against a 3-month average daily volume of 208.6K.

    More News

    Read More
    News headline image
    FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    EXCLUSIVE: FibroBiologics Doses First Patients In Diabetic Foot Ulcers Clinical Trial ↗
    Via Benzinga
    News headline image
    FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics CEO Issues Letter to Shareholders
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Compliant with All Nasdaq Listing Requirements
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces Closing of $3 Million Public Offering
    From FibroBiologics, Inc.
    Via GlobeNewswire
    Which stocks are moving before the opening bell on Wednesday? ↗
    Via Chartmill
    News headline image
    FibroBiologics Announces Pricing of $3 Million Public Offering
    From FibroBiologics, Inc.
    Via GlobeNewswire
    Top movers in Tuesday's after hours session ↗
    Via Chartmill
    News headline image
    FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
    From FibroBiologics, Inc.
    Via GlobeNewswire
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Which stocks are experiencing notable movement on Tuesday? ↗
    Via Chartmill
    The market is filled with gapping stocks in Tuesday's session. ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is FibroBiologics, Inc. - Common Stock publicly traded?
    Yes, FibroBiologics, Inc. - Common Stock is publicly traded.
    What exchange does FibroBiologics, Inc. - Common Stock trade on?
    FibroBiologics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for FibroBiologics, Inc. - Common Stock?
    The ticker symbol for FibroBiologics, Inc. - Common Stock is FBLG on the Nasdaq Stock Market
    What is the current price of FibroBiologics, Inc. - Common Stock?
    The current price of FibroBiologics, Inc. - Common Stock is 0.9900
    When was FibroBiologics, Inc. - Common Stock last traded?
    The last trade of FibroBiologics, Inc. - Common Stock was at 10/16/26 01:19 PM ET
    What is the market capitalization of FibroBiologics, Inc. - Common Stock?
    The market capitalization of FibroBiologics, Inc. - Common Stock is 37.88M
    How many shares of FibroBiologics, Inc. - Common Stock are outstanding?
    FibroBiologics, Inc. - Common Stock has 38M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.